Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $47.7800 (-4.61%) ($47.7800 - $47.7800) on Tue. Dec. 15, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.51% (three month average) | RSI | 83 | Latest Price | $47.7800(-4.61%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 0.3% a day on average for past five trading days. | Weekly Trend | IOVA advances 11.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(48%) XBI(45%) ARKG(44%) IWO(42%) ARKK(39%) | Factors Impacting IOVA price | IOVA will decline at least -1.755% in a week (0% probabilities). VIXM(-23%) UUP(-15%) VXX(-12%) IGOV(-8%) TBT(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.755% (StdDev 3.51%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $48.66(-1.81%) | 10 Day Moving Average | $46.49(2.77%) | 20 Day Moving Average | $42.33(12.88%) | To recent high | -4.6% | To recent low | 70.2% | Market Cap | $6.997b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |